# Vertex Announces $10 Billion Takeover Bid for Crinetics Pharmaceuticals

> ma · REPORTED · 2026-07-13

Vertex Pharmaceuticals announced a $10 billion takeover bid for Crinetics Pharmaceuticals and its rare disease drug Palsonify, marking one of the largest biopharma M&A deals of mid-2026 and expanding Vertex's reach into rare endocrine disorders.

About Vertex Pharmaceuticals: Vertex Pharmaceuticals is a global biotech focused on developing transformative medicines for serious diseases including cystic fibrosis, sickle cell disease, and rare conditions.

- Company: Vertex Pharmaceuticals
- Sector: biotech
- Primary source: https://www.thepharmaletter.com/pharma-news/the-pharma-letter-m-a-round-up-july-2026

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.